
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| KTTA | -60.14% | N/A | N/A | -98% |
| S&P | +13.22% | +85.17% | +13.11% | +53% |
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
No news articles found for Pasithea Therapeutics.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | 0.0% |
| Gross Profit | -$0.18M | -11.9% |
| Market Cap | $5.45M | -3.7% |
| Market Cap / Employee | $1.36M | 0.0% |
| Employees | 4 | -50.0% |
| Net Income | -$3.04M | -1.3% |
| EBITDA | -$2.93M | -3.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $4.22M | -54.9% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | 0.0% |
| Short Term Debt | $0.04M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -83.64% | -19.7% |
| Return On Invested Capital | -41.78% | -13.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.89M | 7.4% |
| Operating Free Cash Flow | -$2.89M | 7.4% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.18 | 0.12 | 0.15 | 0.36 | 2.57% |
| Price to Tangible Book Value | 0.36 | 0.29 | 0.43 | 0.79 | 1.35% |
| Enterprise Value to EBITDA | 0.89 | 0.62 | 0.82 | -0.43 | -133.11% |
| Return on Equity | -72.8% | -82.8% | -85.8% | -89.9% | 31.75% |
| Total Debt | $0.00M | $0.27M | $0.16M | $0.04M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.